Piramal Pharma
PPLPHARMA.NS
#4214
Rank
NZ$4.45 B
Marketcap
NZ$3.36
Share price
-2.89%
Change (1 day)
-35.07%
Change (1 year)

Revenue for Piramal Pharma (PPLPHARMA.NS)

Revenue in 2025 (TTM): NZ$1.79 Billion

According to Piramal Pharma's latest financial reports the company's current revenue (TTM ) is NZ$1.83 Billion. In 2024 the company made a revenue of NZ$1.87 Billion an increase over the revenue in the year 2023 that were of NZ$1.47 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Piramal Pharma from 2022 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$1.79 B-4.1%
2024 NZ$1.87 B26.67%
2023 NZ$1.47 B5.87%
2022 NZ$1.39 B